» Authors » Saravanan Jebarani

Saravanan Jebarani

Explore the profile of Saravanan Jebarani including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 23
Citations 295
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Anjana R, Siddiqui M, Jebarani S, Arun Vignesh M, Kamal Raj N, Unnikrishnan R, et al.
Diabetes Technol Ther . 2021 Oct; 24(3):190-200. PMID: 34609928
To assess the prescribing patterns and response to different classes of antihyperglycemic agents in novel clusters of type 2 diabetes (T2D) described in India. We attempted to replicate the earlier...
12.
Mohan V, Shanthi Rani C, Saboo B, Mukhopadhyay S, Chatterjee S, Dharmarajan P, et al.
Diabetes Technol Ther . 2021 Sep; 24(2):120-129. PMID: 34569820
To compare the clinical profile of long-term survivors and nonsurvivors with type 1 diabetes (T1D) in India. This is a retrospective study of 76 individuals with T1D who had survived...
13.
Kamalraj N, Sathishkumar M, Arunvignesh M, Baskar V, Jebarani S, Amutha A, et al.
Diabetes Metab Syndr . 2021 Aug; 15(5):102261. PMID: 34464909
Aim: To identify the profiles and factors associated with progression/regression of ultrasound-derived hepatic steatosis with type 2 diabetes mellitus seen at a tertiary diabetes center in southern India. Methods: Participants...
14.
Varghese J, Ho J, Anjana R, Pradeepa R, Patel S, Jebarani S, et al.
Diabetes Technol Ther . 2021 Mar; 23(8):555-564. PMID: 33720761
To identify profiles of type 2 diabetes from continuous glucose monitoring (CGM) data using ambulatory glucose profile (AGP) indicators and examine the association with prevalent complications. Two weeks of CGM...
15.
Anjana R, Baskar V, Nair A, Jebarani S, Siddiqui M, Pradeepa R, et al.
BMJ Open Diabetes Res Care . 2020 Aug; 8(1). PMID: 32816869
Introduction: Type 2 diabetes is characterized by considerable heterogeneity in its etiopathogenesis and clinical presentation. We aimed to identify clusters of type 2 diabetes in Asian Indians and to look...
16.
Anjana R, Pradeepa R, Deepa M, Jebarani S, Venkatesan U, Parvathi S, et al.
Diabetes Technol Ther . 2020 Jun; 22(7):527-534. PMID: 32522031
To evaluate the effects of a prolonged lockdown due to Coronavirus (COVID-19) on the adoption of newer technologies and changes in glycemic control on patients with type 2 diabetes (T2D)...
17.
Anjana R, Kesavadev J, Neeta D, Tiwaskar M, Pradeepa R, Jebarani S, et al.
Diabetes Technol Ther . 2017 Sep; 19(9):533-540. PMID: 28930495
Aim: To assess the efficacy of ambulatory glucose profiling (AGP) generated by FreeStyle LibrePro flash glucose monitoring (FCGM) on glycemic control in patients with uncontrolled type 1 diabetes (T1D) and...
18.
Unnikrishnan R, Anjana R, Amutha A, Ranjani H, Jebarani S, Ali M, et al.
J Diabetes Complications . 2017 Apr; 31(6):971-975. PMID: 28410927
Aims: To compare the clinical profile and complications between younger and older onset type 2 diabetes (T2DM) patients at a tertiary care diabetes center in south India. Methods: We compared...
19.
PramodKumar T, Priya M, Jebarani S, Anjana R, Mohan V, Pradeepa R
Indian J Endocrinol Metab . 2016 Oct; 20(5):612-618. PMID: 27730069
Aim: The aim of this study was to compare the metabolic profiles of subjects with normal glucose tolerance (NGT) with and without elevated 1-h postglucose (1HrPG) values during an oral...
20.
Mahalakshmi M, Bhavadharini B, Maheswari K, Anjana R, Jebarani S, Ninov L, et al.
Indian J Endocrinol Metab . 2016 May; 20(3):364-8. PMID: 27186555
Aim: To obtain information on existing practices in the diagnosis and management of gestational diabetes mellitus (GDM) among physicians/diabetologists/endocrinologists and obstetricians/gynecologists (OB/GYNs) in India. Methods: Details regarding diagnostic criteria used,...